University of Colorado Grants License to Cirena for RNA-Synthesis Technology
March 11, 2026
Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision BOULDER, CO – Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology, giving researchers scalable access to high purity 100-400nt RNA constructs for next-generation therapeutics. The agreement brings to market an approach developed [...]
March 11, 2026
Siemens brings world-class capabilities in industrial AI, digital twin technology, and engineering to DOE’s Genesis Mission, building on its longstanding collaboration Today, Siemens announced it has signed a Memorandum of Understanding (MOU) with the U.S. Department of Energy (DOE) to support the Genesis Mission, a federal initiative to modernize America’s scientific infrastructure and strengthen the [...]
Gore Expands Leadership in Membrane Chromatography with Next-Generation Affinity Solutions
March 11, 2026
W. L. Gore & Associates (Gore) is collaborating with customized ligand partners to introduce a new range of high-performance affinity membrane chromatography products. This initiative expands Gore’s presence in the bioprocessing industry beyond Protein A-based solutions, further advancing purification performance and scalability for biopharmaceutical manufacturers. NEWARK, Del. -- W. L. Gore & Associates, Inc. ("Gore"), [...]
Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis
March 10, 2026
Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. - Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in [...]
March 10, 2026
Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of Designer Drugs, the essential GC‑MS spectral database used by forensic laboratories worldwide for the rapid identification of illicit substances. As the landscape of novel psychoactive substances (NPS) continues [...]
Introducing the WelPrep 2000 G2: The Next Evolution in Preparative HPLC
March 10, 2026
Introduction As laboratory purification requirements continue to evolve, the demand for higher efficiency, precision, and environmental sustainability has become paramount. Building upon the robust foundation of its predecessor, Welch Materials is proud to announce the official release of the WelPrep 2000 G2 Preparative High-Performance Liquid Chromatography System. This second-generation system is the result of deep technical refinement and [...]
mAbxience Selects Genedata Bioprocess to Automate End-to-End CDMO Workflows
March 10, 2026
Purpose-built enterprise SaaS solution streamlines bioprocess workflows and accelerates digital transformation for global biopharmaceutical development Basel, Switzerland — Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess® enterprise platform to structure and harmonize all bioprocess development data across its operations. [...]
LabWare Highlights SaaS Evolution and LabWare ASSURE at Pittcon 2026
March 10, 2026
-Trusted, unified laboratory informatics designed for fast go-lives and incremental scale- LabWare, a global leader in laboratory informatics, showcases at this year’s Pittcon Conference how laboratories can move away from legacy, slow-to-change LIMS models and adopt low-cost, fast-to-implement SaaS LIMS grounded in industry best practices. The press briefing will focus on how LabWare helps labs [...]
March 10, 2026
Zeist, The Netherlands – Scinus Group today announced the successful closing of a €3 million strategic investment round led by Myosotis Investments, founded by biotech entrepreneur Wietse Mulder. Existing shareholders, including the company’s founders and the Demcon Innovation Fund, also participated in the round.The investment marks an important milestone in Scinus’ development and will support the accelerated commercial roll-out of the Osilaris™ [...]
March 10, 2026
Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of Designer Drugs, the essential GC‑MS spectral database used by forensic laboratories worldwide for the rapid identification of illicit substances. As the landscape of novel psychoactive substances (NPS) continues [...]

